Patents by Inventor Robert W. Sessions

Robert W. Sessions has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8486454
    Abstract: The present invention provides a method of attenuating the formation or reducing the severity of neurogenic pain in the tissue of a patient via applying a composition comprising a hydrophilic foam substrate and a polymeric hydrophilic agent to a portion of the surface of the skin in an amount and at a location sufficient to attenuate formation of or reduce the severity of neurogenic pain.
    Type: Grant
    Filed: September 29, 2006
    Date of Patent: July 16, 2013
    Assignee: Sessions Pharmaceuticals Inc.
    Inventors: Robert W. Sessions, Alan R. Kahn
  • Patent number: 8101206
    Abstract: The present invention provides a method of attenuating the formation or reducing the severity of swelling and/or inflammation in the tissue of a patient via applying a composition comprising a hydrophilic foam substrate and a polymeric hydrophilic agent to a portion of the surface of the skin in an amount and at a location sufficient to attenuate formation of or reduce the severity of swelling and/or inflammation.
    Type: Grant
    Filed: September 29, 2006
    Date of Patent: January 24, 2012
    Assignee: Sessions Pharmaceuticals Inc.
    Inventors: Robert W. Sessions, Alan R. Kahn
  • Patent number: 7875294
    Abstract: The present invention provides a method of attenuating the formation or reducing the severity of a bruise in the tissue of a patient via applying a composition comprising a hydrophilic foam substrate and a polymeric hydrophilic agent to a portion of the surface of the skin in an amount and at a location sufficient to attenuate formation of or reduce the severity of bruising.
    Type: Grant
    Filed: September 28, 2006
    Date of Patent: January 25, 2011
    Assignee: Sessions Pharmaceuticals Inc.
    Inventors: Robert W. Sessions, Roger Sessions, legal representative, Alan R. Kahn
  • Publication number: 20100267640
    Abstract: The present invention provides a method of attenuating the formation or reducing the severity of neurogenic swelling and/or neurogenic inflammation in the tissue of a patient via applying a composition comprising a hydrophilic foam substrate and a polymeric hydrophilic agent to a portion of the surface of the skin in an amount and at a location sufficient to attenuate formation of or reduce the severity of neurogenic swelling and/or neurogenic inflammation.
    Type: Application
    Filed: April 26, 2010
    Publication date: October 21, 2010
    Applicant: Sessions Pharmaceuticals, Inc.
    Inventors: Robert W. Sessions, Alan R. Kahn
  • Patent number: 7709005
    Abstract: The present invention provides a method of attenuating the formation or reducing the severity of neurogenic swelling and/or neurogenic inflammation in the tissue of a patient via applying a composition comprising a hydrophilic foam substrate and a polymeric hydrophilic agent to a portion of the surface of the skin in an amount and at a location sufficient to attenuate formation of or reduce the severity of neurogenic swelling and/or neurogenic inflammation.
    Type: Grant
    Filed: September 29, 2006
    Date of Patent: May 4, 2010
    Assignee: Sessions Pharmaceuticals Inc.
    Inventors: Robert W. Sessions, Alan R. Kahn
  • Patent number: 7625585
    Abstract: The present invention provides a method of attenuating the formation or reducing the severity of a neurogenic bruise in the tissue of a patient via applying a composition comprising a hydrophilic foam substrate and a polymeric hydrophilic agent to a portion of the surface of the skin in an amount and at a location sufficient to attenuate formation of or reduce the severity of bruising.
    Type: Grant
    Filed: May 25, 2006
    Date of Patent: December 1, 2009
    Assignee: Sessions Pharmaceuticals Inc.
    Inventors: Robert W. Sessions, Alan R. Kahn
  • Patent number: 7078055
    Abstract: The present invention provides a method of attenuating swelling or inflammation in the tissue of a patient via applying a composition comprising a hydrophilic foam substrate and a polymeric hydrophilic agent capable of absorbing water to a portion of the surface of the skin of the patient in an amount and at a location sufficient to attenuate swelling or inflammation.
    Type: Grant
    Filed: June 19, 2002
    Date of Patent: July 18, 2006
    Assignee: Ferris Pharmaceuticals Inc.
    Inventors: Robert W. Sessions, Alan R. Kahn
  • Patent number: 7078056
    Abstract: The present invention provides a method of attenuating the formation or reducing the severity of a bruise in the tissue of a patient via applying a composition comprising a hydrophilic foam substrate and a polymeric hydrophilic agent to a portion of the surface of the skin in an amount and at a location sufficient to attenuate formation of or reduce the severity of bruising.
    Type: Grant
    Filed: September 19, 2002
    Date of Patent: July 18, 2006
    Assignee: Ferris Pharmaceuticals Inc.
    Inventors: Robert W. Sessions, Alan R. Kahn
  • Patent number: 7022890
    Abstract: The invention provides a wound dressing comprising a body and a polymeric film adhered to at least a portion of the body. The body comprises a flexible, porous polyurethane-based foam and a liquid absorbing component. The invention further provides a wound dressing comprising a first body, a second body, and at least one polymeric film disposed between the first and second bodies. The invention additionally provides methods for treating an injury to a patient's nasal passages utilizing a wound dressing according to the invention.
    Type: Grant
    Filed: September 22, 2004
    Date of Patent: April 4, 2006
    Assignee: Ferris Pharmaceuticals
    Inventor: Robert W. Sessions
  • Patent number: 6794554
    Abstract: Wound packing material comprising a resilient polymer-based foam sheet of a predetermined thickness. The foam sheet includes at least one slit of a predetermined length that extends from the foam surface into the foam to a predetermined depth. This slit, or slits, permits the foam, when folded upon itself, to occupy a smaller volume than the foam would occupy when folded over upon itself in the same manner, but in the absence of the slit.
    Type: Grant
    Filed: February 1, 2001
    Date of Patent: September 21, 2004
    Assignee: Ferris Pharmaceuticals, Inc.
    Inventors: Robert W. Sessions, Roy D. Carr
  • Patent number: 6768040
    Abstract: Wound dressing for a nasal cavity comprising a flexible, porous polyurethane-based foam comprising a liquid-absorbing component, wherein the dressing is provided in a in a shape acceptable for insertion into a nasal cavity, e.g., cylindrical, conical or frustro-conical shape.
    Type: Grant
    Filed: March 27, 2000
    Date of Patent: July 27, 2004
    Assignee: Ferris Pharmaceuticals Inc.
    Inventors: Robert W. Sessions, Richard A. Rodzen
  • Publication number: 20020182230
    Abstract: The present invention provides a method of attenuating swelling or inflammation in the tissue of a patient via applying a composition comprising a hydrophilic foam substrate and a polymeric hydrophilic agent capable of absorbing water to a portion of the surface of the skin of the patient in an amount and at a location sufficient to attenuate swelling or inflammation.
    Type: Application
    Filed: June 19, 2002
    Publication date: December 5, 2002
    Applicant: Ferris Corporation
    Inventors: Robert W. Sessions, Alan R. Kahn
  • Publication number: 20020182173
    Abstract: The present invention provides a method of attenuating the formation or reducing the severity of a bruise in the tissue of a patient via applying a composition comprising a hydrophilic foam substrate and a polymeric hydrophilic agent to a portion of the surface of the skin in an amount and at a location sufficient to attenuate formation of or reduce the severity of bruising.
    Type: Application
    Filed: June 19, 2002
    Publication date: December 5, 2002
    Applicant: Ferris Corporation
    Inventors: Robert W. Sessions, Alan R. Kahn
  • Patent number: 6451301
    Abstract: The present invention provides a method of attenuating the response of nociceptors to noxious stimuli by applying a composition comprising a hydrophilic foam substrate, a polymeric hydrophilic agent capable of absorbing water to the surface of the skin. In other aspects, the present invention provides a method of preventing the formation of a bruise in traumatized tissue, a method of attenuating swelling, a method of attenuating neurogenic inflammatory response, and a method of reducing the sensation of pain by applying like compositions to the surface of the skin of patients.
    Type: Grant
    Filed: June 7, 1999
    Date of Patent: September 17, 2002
    Assignee: Ferris Corporation
    Inventors: Robert W. Sessions, Alan R. Kahn
  • Patent number: 6447802
    Abstract: The present invention provides a method of attenuating the formation of a bruise and a method of attenuating swelling or inflammation in the tissue of a patient via applying a composition comprising a hydrophilic foam substrate and a polymeric hydrophilic agent capable of absorbing water to the surface of the skin.
    Type: Grant
    Filed: February 20, 2001
    Date of Patent: September 10, 2002
    Assignee: Ferris Corporation
    Inventors: Robert W. Sessions, Alan R. Kahn
  • Patent number: 6349828
    Abstract: Tamper-evident packaging for a product, e.g., a wound dressing or other sterile medical device. The packaging comprises a top sheet and a bottom sheet, the top sheet sealed to the bottom sheet about the product so as to seal the product between the top and bottom sheets, wherein the portion of the top and bottom sheets that are sealed to each other define sealing areas. The top sheet has at least one perforation in its sealing area so that when the sheets are separated from one another, the top sheet tears adjacent to the at least one perforation, indicating that the package has been at least partially opened.
    Type: Grant
    Filed: February 6, 1997
    Date of Patent: February 26, 2002
    Assignee: Ferris Pharmaceuticals Inc.
    Inventors: Robert W. Sessions, Rainer Schmeichel
  • Patent number: 6350339
    Abstract: A non-stretchable wound dressing has a flexible, non-stretching cover sheet having adhesive on one side thereof, and having two spaced strip-form gripping tabs at opposite ends thereof. The cover sheet covers a urethane wound dressing with the adhesive of the cover sheet being in contact with the urethane, and the urethane having an adhesive layer on an opposite side thereof. For storage and prior to application to a patient, the adhesive of the urethane wound dressing is in contact with a releasable surface of a carrier, such as cardboard. For application to a patient, one of the cover sheet gripping tabs is pulled so as to release the cover sheet and wound dressing from the carrier, the cover sheet preventing stretching of the wound dressing. The combination is then applied to a patient, again the cover sheet preventing stretching of the wound dressing.
    Type: Grant
    Filed: March 2, 1995
    Date of Patent: February 26, 2002
    Assignee: Ferris Pharmaceuticals Inc.
    Inventor: Robert W. Sessions
  • Patent number: 6346653
    Abstract: A non-stretching wound dressing is provided for use with a patient. The wound dressing includes a cover sheet having top and bottom sides, a thin film sheet formed on the bottom side of the cover sheet, the film sheet having first and second ends and an adhesive side, and a carrier sheet in adjacent contact with the adhesive side of the thin film sheet. The dressing also includes a first gripping tab attached to one end of the thin film sheet and disposed between the film sheet and the carrier sheet for separating the carrier sheet from the film sheet with the cover sheet remaining affixed to the film sheet. A second gripping tab is attached to the top side of the cover sheet and at one end of the cover sheet so that pulling on the second gripping tab releases the cover sheet from the film sheet with the film sheet remaining in place on the patient.
    Type: Grant
    Filed: January 24, 2000
    Date of Patent: February 12, 2002
    Assignee: Ferris Mfg. Corp.
    Inventors: Robert W. Sessions, Rainer Schmeichel
  • Publication number: 20010034499
    Abstract: Wound packing material comprising a resilient polymer-based foam sheet of a predetermined thickness. The foam sheet includes at least one slit of a predetermined length that extends from the foam surface into the foam to a predetermined depth. This slit, or slits, permits the foam, when folded upon itself, to occupy a smaller volume than the foam would occupy when folded over upon itself in the same manner, but in the absence of the slit.
    Type: Application
    Filed: February 1, 2001
    Publication date: October 25, 2001
    Inventors: Robert W. Sessions, Roy D. Carr
  • Publication number: 20010009676
    Abstract: The present invention provides a method of attenuating the formation of a bruise and a method of attenuating swelling or inflammation in the tissue of a patient via applying a composition comprising a hydrophilic foam substrate and a polymeric hydrophilic agent capable of absorbing water to the surface of the skin.
    Type: Application
    Filed: February 20, 2001
    Publication date: July 26, 2001
    Inventors: Robert W. Sessions, Alan R. Kahn